Artivion (AORT) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Artivion Revenue Highlights

Latest Revenue (Y)

$388.54M

Latest Revenue (Q)

$98.98M

Main Segment (Y)

Products

Main Geography (Y)

North America Segment

Artivion Revenue by Period

Artivion Revenue by Year

Date	Revenue	Change
2024-12-31	$388.54M	9.75%
2023-12-31	$354.00M	12.82%
2022-12-31	$313.79M	5.00%
2021-12-31	$298.84M	18.01%
2020-12-31	$253.23M	-8.32%
2019-12-31	$276.22M	5.09%
2018-12-31	$262.84M	38.55%
2017-12-31	$189.70M	5.17%
2016-12-31	$180.38M	23.63%
2015-12-31	$145.90M	0.87%
2014-12-31	$144.64M	2.75%
2013-12-31	$140.76M	6.87%
2012-12-31	$131.72M	10.11%
2011-12-31	$119.63M	2.56%
2010-12-31	$116.64M	4.44%
2009-12-31	$111.69M	6.31%
2008-12-31	$105.06M	10.87%
2007-12-31	$94.76M	16.54%
2006-12-31	$81.31M	17.36%
2005-12-31	$69.28M	11.06%
2004-12-31	$62.38M	4.79%
2003-12-31	$59.53M	-23.48%
2002-12-31	$77.80M	-11.26%
2001-12-31	$87.67M	13.72%
2000-12-31	$77.10M	15.55%
1999-12-31	$66.72M	9.92%
1998-12-31	$60.70M	19.25%
1997-12-31	$50.90M	37.57%
1996-12-31	$37.00M	27.59%
1995-12-31	$29.00M	22.88%
1994-12-31	$23.60M	11.32%
1993-12-31	$21.20M	-

Artivion generated $388.54M in revenue during NA 2024, up 9.75% compared to the previous quarter, and up 140.66% compared to the same period a year ago.

Artivion Revenue by Quarter

Date	Revenue	Change
2025-03-31	$98.98M	1.72%
2024-12-31	$97.31M	1.60%
2024-09-30	$95.78M	-2.29%
2024-06-30	$98.02M	0.60%
2024-03-31	$97.43M	4.02%
2023-12-31	$93.67M	6.62%
2023-09-30	$87.85M	-1.57%
2023-06-30	$89.25M	7.24%
2023-03-31	$83.23M	4.83%
2022-12-31	$79.40M	3.33%
2022-09-30	$76.84M	-4.36%
2022-06-30	$80.34M	4.05%
2022-03-31	$77.21M	-2.75%
2021-12-31	$79.39M	9.95%
2021-09-30	$72.21M	-5.18%
2021-06-30	$76.15M	7.12%
2021-03-31	$71.09M	4.70%
2020-12-31	$67.90M	4.25%
2020-09-30	$65.13M	21.13%
2020-06-30	$53.77M	-19.05%
2020-03-31	$66.43M	-4.69%
2019-12-31	$69.70M	2.68%
2019-09-30	$67.88M	-4.58%
2019-06-30	$71.14M	5.38%
2019-03-31	$67.50M	-0.43%
2018-12-31	$67.80M	4.96%
2018-09-30	$64.60M	-5.69%
2018-06-30	$68.50M	10.57%
2018-03-31	$61.95M	17.27%
2017-12-31	$52.83M	20.06%
2017-09-30	$44.00M	-7.99%
2017-06-30	$47.82M	6.12%
2017-03-31	$45.06M	0.07%
2016-12-31	$45.03M	-0.49%
2016-09-30	$45.25M	-3.89%
2016-06-30	$47.08M	9.45%
2016-03-31	$43.02M	7.98%
2015-12-31	$39.84M	8.54%
2015-09-30	$36.70M	3.31%
2015-06-30	$35.53M	5.01%
2015-03-31	$33.83M	-8.94%
2014-12-31	$37.15M	0.22%
2014-09-30	$37.07M	6.86%
2014-06-30	$34.69M	-2.91%
2014-03-31	$35.73M	0.77%
2013-12-31	$35.46M	-2.19%
2013-09-30	$36.25M	8.14%
2013-06-30	$33.52M	-5.67%
2013-03-31	$35.54M	8.34%
2012-12-31	$32.80M	-1.88%
2012-09-30	$33.43M	0.73%
2012-06-30	$33.19M	2.75%
2012-03-31	$32.30M	6.26%
2011-12-31	$30.40M	2.51%
2011-09-30	$29.65M	0.94%
2011-06-30	$29.38M	-2.71%
2011-03-31	$30.20M	3.33%
2010-12-31	$29.22M	2.74%
2010-09-30	$28.44M	-2.80%
2010-06-30	$29.26M	-1.53%
2010-03-31	$29.72M	3.85%
2009-12-31	$28.61M	1.40%
2009-09-30	$28.22M	0.20%
2009-06-30	$28.16M	5.53%
2009-03-31	$26.69M	4.53%
2008-12-31	$25.53M	-4.75%
2008-09-30	$26.80M	-1.29%
2008-06-30	$27.16M	6.21%
2008-03-31	$25.57M	1.99%
2007-12-31	$25.07M	-

Artivion generated $98.98M in revenue during Q1 2025, up 1.72% compared to the previous quarter, and up 105.67% compared to the same period a year ago.

Artivion Revenue Breakdown

Artivion Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Surgical Sealants	$73.90M	$68.02M	$65.38M	$70.71M	-
Aortic Stent Grafts	$123.08M	$107.47M	-	-	-
Products	$290.23M	$261.19M	$230.35M	$221.60M	$179.30M
Other Products	$9.27M	$11.17M	$8.32M	$8.13M	-
On X	$83.98M	$74.53M	$63.90M	$57.36M	$48.05M
Aortic Stents And Stent Grafts	-	-	$92.75M	$85.39M	$61.66M
Preservation Services	-	-	$83.44M	$77.24M	$73.93M
Cardiac Tissue	-	-	-	-	$37.89M
Bioglue	-	-	-	-	$62.07M
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	$464.00K
Neopatch	-	-	-	-	$183.00K
Per Clot	-	-	-	-	$2.88M
Photofix	-	-	-	-	$4.17M
Vascular Tissue	-	-	-	-	$35.85M

Artivion's latest annual revenue breakdown by segment (product or service), as of Dec 24: Products (50.00%), Aortic Stent Grafts (21.20%), On X (14.47%), Surgical Sealants (12.73%), and Other Products (1.60%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Aortic Stent Grafts	$39.84M	$36.60M	$62.34M	$28.64M	$32.10M	$27.44M	$25.52M	$28.36M	$26.15M	$19.67M	$23.83M	$25.51M	-	-	-	-	-	-	-	-
On X	$25.57M	$21.57M	$42.82M	$21.48M	$19.68M	$20.18M	$18.74M	$17.95M	$17.66M	$16.46M	$16.25M	$14.37M	$14.02M	$14.73M	$13.10M	$13.67M	$12.07M	$10.12M	$12.20M	-
Other Products	$2.74M	$2.52M	$4.23M	$2.69M	$2.35M	$3.01M	$3.25M	$3.13M	$1.78M	$1.74M	$2.88M	$1.98M	$1.65M	$2.42M	$2.22M	-	-	-	-	-
Preservation Services	$25.53M	$17.39M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Products	$87.44M	$78.80M	$147.87M	$71.24M	$71.11M	$69.14M	$63.75M	$66.00M	$62.29M	$55.25M	$58.94M	$57.54M	$53.11M	$56.08M	$53.34M	$50.50M	-	-	-	-
Surgical Sealants	$19.29M	$18.11M	$38.48M	$18.44M	$16.98M	$18.51M	$16.23M	$16.57M	$16.70M	$17.37M	$15.97M	$15.68M	$16.54M	$17.86M	$17.83M	-	-	-	-	-
International Hospitals	-	-	-	-	-	-	-	-	-	$25.30M	-	-	-	-	-	-	-	-	-	-
International Distributor	-	-	-	-	-	-	-	-	-	$12.92M	-	-	-	-	-	-	-	-	-	-
Domestic Hospitals	-	-	-	-	-	-	-	-	-	$40.79M	-	-	-	-	-	-	-	-	-	-
Cardiogenesis	-	-	-	-	-	-	-	-	-	$389.00K	-	-	-	-	-	-	-	-	-	-
Aortic Stents And Stent Grafts	-	-	-	-	-	-	-	-	-	-	-	-	-	$20.90M	$21.06M	$20.20M	-	-	-	-
Per Clot	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$801.00K	$724.00K	$497.00K	$860.00K
Photofix	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.11M	$1.13M	$880.00K	$1.04M
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$106.00K	$83.00K	$164.00K	$111.00K
Cardiac Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.13M	$10.68M	$8.06M	$10.03M
Bioglue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.08M	$15.81M	$12.44M	$16.74M
Vascular Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.20M	$9.29M	$9.98M	-
Neopatch	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.00K	$58.00K	-	-
Jotec Ag	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.29M	$13.17M	$15.27M
Nexus	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$200.00K

Artivion's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Products (43.63%), Aortic Stent Grafts (19.88%), On X (12.76%), Preservation Services (12.74%), Surgical Sealants (9.62%), and Other Products (1.37%).

Artivion Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
North America Segment	$197.94M	-	-	-	-
Asia Pacific Segment	$37.20M	-	-	-	-
Europe, the Middle East, and Africa Segments	$131.52M	-	-	-	-
Latin America Segment	$21.88M	-	-	-	-
Non-US	-	$174.52M	$152.68M	-	-
UNITED STATES	-	$179.49M	$161.11M	-	-
U	-	-	-	$151.15M	$138.27M
Non Us	-	-	-	$147.69M	$114.95M

Artivion's latest annual revenue breakdown by geography, as of Dec 24: North America Segment (50.94%), Europe, the Middle East, and Africa Segments (33.85%), Asia Pacific Segment (9.57%), and Latin America Segment (5.63%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24
Latin America Segment	$5.56M	$5.93M	$10.67M	$5.90M	$5.31M
Asia Pacific Segment	$11.13M	$8.21M	$19.23M	$10.37M	$7.61M
Europe, the Middle East, and Africa Segments	$38.71M	$37.05M	$67.51M	$30.42M	$33.59M
North America Segment	$57.57M	$47.79M	$97.92M	$49.09M	$50.93M

Artivion's latest quarterly revenue breakdown by geography, as of Jun 25: North America Segment (50.96%), Europe, the Middle East, and Africa Segments (34.27%), Asia Pacific Segment (9.85%), and Latin America Segment (4.92%).

Artivion Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
AVAH	Aveanna Healthcare	$2.02B	$589.55M
LFST	LifeStance Health Group	$1.25B	$345.31M
ANIP	ANI Pharmaceuticals	$614.38M	$197.12M
ATEC	Alphatec	$424.26M	-
AORT	Artivion	$388.54M	$98.98M
PRCT	PROCEPT BioRobotics	$224.50M	$79.18M
LMAT	LeMaitre Vascular	$219.86M	$64.23M
BGM	BGM Group	$25.10M	$12.56M
SSII	SS Innovations	$20.65M	$5.12M
VERA	Vera Therapeutics	-	-

AORT Revenue FAQ

What is Artivion’s yearly revenue?

Artivion's yearly revenue for 2024 was $388.54M, representing an increase of 9.75% compared to 2023. The company's yearly revenue for 2023 was $354M, representing an increase of 12.82% compared to 2022. AORT's yearly revenue for 2022 was $313.79M, representing an increase of 5.00% compared to 2021.

What is Artivion’s quarterly revenue?

Artivion's quarterly revenue for Q1 2025 was $98.98M, a 1.72% increase from the previous quarter (Q4 2024), and a 1.59% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $97.31M, a 1.60% increase from the previous quarter (Q3 2024), and a 3.88% increase year-over-year (Q4 2023). AORT's quarterly revenue for Q3 2024 was $95.78M, a -2.29% decrease from the previous quarter (Q2 2024), and a 9.02% increase year-over-year (Q3 2023).

What is Artivion’s revenue growth rate?

Artivion's revenue growth rate for the last 3 years (2022-2024) was 23.82%, and for the last 5 years (2020-2024) was 53.43%.

What are Artivion’s revenue streams?

Artivion's revenue streams in c 24 are Surgical Sealants, Aortic Stent Grafts, Products, Other Products, and On X. Surgical Sealants generated $73.9M in revenue, accounting 12.73% of the company's total revenue, up 8.65% year-over-year. Aortic Stent Grafts generated $123.08M in revenue, accounting 21.20% of the company's total revenue, up 14.53% year-over-year. Products generated $290.23M in revenue, accounting 50.00% of the company's total revenue, up 11.12% year-over-year. Other Products generated $9.27M in revenue, accounting 1.60% of the company's total revenue, down -17.03% year-over-year. On X generated $83.98M in revenue, accounting 14.47% of the company's total revenue, up 12.69% year-over-year.

What is Artivion’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Artivion was Products. This segment made a revenue of $290.23M, representing 50.00% of the company's total revenue.